Clinical Study of Pulmonary Metastases from Primary Bone Tumors
نویسندگان
چکیده
منابع مشابه
FDG-PET for detection of pulmonary metastases from malignant primary bone tumors: comparison with spiral CT.
BACKGROUND The purpose was the comparison of positron emission tomography using F-18-fluorodeoxy-glucose (FDG-PET) and spiral thoracic CT to detect pulmonary metastases from malignant primary osseous tumors. PATIENTS AND METHODS In 71 patients with histologically confirmed malignant primary bone tumors (32 osteosarcomas, 39 Ewing's sarcomas) 111 FDG-PET examinations were evaluated with regard...
متن کاملSurgical treatment of pulmonary metastases from primary tumours of bone.
Interest in lung resection for metastatic malignant disease has steadily increased since it became apparent that in carefully selected patients the results in terms of prolongation of life could be surprisingly good. Indeed the outcome after such resection for metastases of all kinds compares favourably with those to be expected following resection of primary tumours of the lung (Smith 1963, Cl...
متن کاملTyrosine kinase expression in pulmonary metastases and paired primary tumors.
Tyrosine kinase inhibitors against the receptors of vascular endothelial growth factor (VEGFR), epidermal growth factor (EGFR) and the platelet derived growth factor (PDGFR) are increasingly used in the treatment of progressive cancers. However, the expression of these receptors especially in lung metastases has not been examined. Tissue specimen from 35 lung metastases of 33 patients with rena...
متن کاملBone metastases and skeletal-related events from neuroendocrine tumors
Neuroendocrine tumors (NETs) metastasize to bone; however, a multi-institution evaluation of the natural history and complications of bone metastases across multiple NET subtypes has not, to our knowledge, previously been conducted. At two tertiary academic centers, we identified patients with bone metastases from databases of patients with a diagnosis of NET between 2004 and 2008. Detection of...
متن کاملCancer Therapy: Clinical Denosumab Dose Selection for Patients with Bone Metastases from Solid Tumors
Purpose: To quantitatively characterize the longitudinal dose exposure–response [urinaryN-telopeptide normalized to urinary creatinine (uNTx/Cr) suppression] relationship for denosumab in patients with bone metastases from solid tumors. Experimental Design: Data from 373 patients who received denosumab as single or multiple subcutaneous doses ranging from 30 to 180mg (or 0.01 to 3mg/kg) adminis...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Haigan
سال: 1972
ISSN: 1348-9992,0386-9628
DOI: 10.2482/haigan.12.27